Table 1.
S. pneumoniae Macrolide Resistance Rates by Setting and US Census Region
% Resistant (No. Tested) | ||||
---|---|---|---|---|
Setting or Region | No. of Facilities | Blood Isolates | Respiratory Isolates | All Isolates |
Total | 329a | 29.6 (1591) | 47.3 (2035) | 39.5 (3626) |
Inpatient | 313 | 28.2 (1211) | 45.2 (1587) | 37.8 (2798) |
Ambulatory | 231 | 33.9 (380) | 54.9 (448) | 45.3 (828) |
Census region (states) | ||||
West North Central (IA, KS, MN, MO, ND, NE, SD) | 12 | 52.1 (48) | 55.0 (131) | 54.2 (179) |
South Atlantic (DE, DC, FL, GA, MD, NC, SC, VA, WV) | 40 | 30.3 (145) | 60.8 (199) | 48.0 (344) |
East South Central (AL, KY, MS, TN) | 49 | 38.0 (229) | 55.6 (252) | 47.2 (481) |
West South Central: (AR, LA, OK, TX) | 71 | 35.6 (455) | 48.5 (643) | 43.2 (1098) |
East North Central: (IL, IN, MI, OH, WI) | 56 | 29.0 (217) | 49.7 (320) | 41.3 (537) |
Middle Atlantic (NJ, NY, PA) | 50 | 28.3 (191) | 39.8 (236) | 34.7 (427) |
Pacific (AK, CA, OR, WA) | 36 | 13.2 (257) | 25.3 (190) | 18.3 (447) |
New England (CT, MA, ME, NH, RI, VT) | 5 | 4.0 (25) | 25.0 (52) | 18.2 (77) |
Mountain (AZ, CO, ID, MT, NM, NV, UT, WY) | 10 | 4.2 (24) | 33.3 (12) | 13.9 (36) |
aFacilities could provide both inpatient and ambulatory services.